BioSpace News Archive

LexisNexis® Risk Solutions Risk Defense Platform service has been approved by Kantara Initiative as a Component Service, in compliance with the requirements of NIST SP 800-63 rev.3 (Technical) Class of Approval, at Identity Assurance Level 2 (IAL2).

Titan Medical Inc. today announced the appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs.

CytomX Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated antibody therapeutics based on its Probody® technology platform, announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in the following virtual investor conferences in August.

Windtree Therapeutics, Inc. announced the appointment of Randall White, Ph.D., as Vice President, Clinical Program Management, reporting to Steve Simonson, M.D., Senior Vice President and Chief Medical Officer of Windtree.

Parexel, a leading global clinical research organization focused on development and delivery of innovative new therapies to advance patient health, announced that two of its visionary leaders have been named to the PharmaVOICE 100 list of the most inspiring people in the life sciences industry.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company primarily focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, August 9, 2021, t

Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced that it will release earnings for the quarter ending June 30, 2021 before market open on August 12, 2021.

The global smart syringe market is driven by rise in count of needle stick injuries, shift from conventional syringes to smart syringes, growth in awareness in emerging economies, and widespread adoption of safety syringes across all applications, especially in drug delivery.

Butterfly needle is a device utilized to draw blood from an access vein or deliver intravenous (IV) therapy through a vein.